Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Tags :Forbion
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
